SCHEMBL10569707

SCHEMBL10569707

Oc1ccc(CCc2cnc(S)[nH]2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.50
▸ ESR2 Q92731 1/20 0.50
▸ LTA4H P09960 1/20 0.47
▸ CA2 P00918 1/20 0.41
▸ GPR84 Q9NQS5 9/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ BLM P54132 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10569546 0.90 SLC28A3 (0.46) ESR1ESR2LTA4HCA2GPR84
SCHEMBL10566495 0.90 IGF1R (0.47) ESR1ESR2LTA4HCA2GPR84
SCHEMBL10569187 0.78 DAO (0.50) TAAR1IGF1RALOX15
SCHEMBL10567365 0.71 AOC3 (0.42) —
SCHEMBL3873458 0.71 ESR1 (1.00) ESR1ESR2LTA4HCA2KDM4E
SCHEMBL69344 0.71 ESR1 (1.00) ESR1ESR2LTA4HCA2KDM4E
SCHEMBL6851114 0.70 — —
SCHEMBL10570142 0.68 CDK5 (0.43) ESR1ESR2L3MBTL1KMT2A
SCHEMBL9553194 0.68 ESR1 (0.50) ESR1ESR2LTA4HCA2GPR84
SCHEMBL8425150 0.67 ESR1 (0.68) ESR1ESR2LTA4HCA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0302603-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1989-02-08 — — EP claimed
US-4798843-A HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1989-01-17 — — US claimed
EP-0302603-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 1989-02-08 — — EP disclosed
US-4798843-A HYPOTENSIVE AGENTS SMITHKLINE BECKMAN CORPORATION (US) 1989-01-17 — — US disclosed
Send feedback